Reversal of Remimazolam by a Single Dose of Flumazenil
Status:
Not yet recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
Remimazolam, a brand-new sedative which has benzodiazepine property. It is an ultra-short
acting sedative and regarded as a proper drug for procedural sedation.